Brands and Their Owners
Welcome to the Brand page for “VALERA MESSENGER VACCINES”, which is offered here for Vaccines; pharmaceutical preparations, nucleic acid preparations for the treatment and prevention of infectious diseases; medicines, nucleic acid therapeutics for the treatment and prevention of infectious diseases; biological preparations, nucleic acid preparations for the prevention and treatment of infectious diseases; biotherapeutics, nucleic acid therapeutics for the prevention and treatment of infectious diseases; biosimilars in the nature of therapeutic agents, nucleic acid therapeutics for the prevention and treatment of infectious diseases; vaccine adjuvants;messenger vaccines;scientific research in the fields of immunopharmaceuticals and vaccines; scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics for the prevention and treatment of infections or diseases;.
Its status is currently believed to be active. Its class is unavailable. “VALERA MESSENGER VACCINES” is believed to be currently owned by “ModernaTX, Inc.”
Owner: |
MODERNATX, INC.
Owner Details |
---|---|
Description: |
Vaccines; pharmaceutical preparations, nucleic acid preparations for the treatment and prevention of infectious diseases; medicines, nucleic acid therapeutics for the treatment and prevention of infectious diseases; biological preparations, nucleic acid preparations for the prevention and treatment of infectious diseases; biotherapeutics, nucleic acid therapeutics for the prevention and treatment of infectious diseases; biosimilars in the nature of therapeutic agents, nucleic acid therapeutics for the prevention and treatment of infectious diseases; vaccine adjuvants;MESSENGER VACCINES;Scientific research in the fields of immunopharmaceuticals and vaccines; scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics for the prevention and treatment of infections or diseases;
|
Categories: | VACCINES |